Meghan Scanlon, SVP, President, Urology Pelvic Health at BOSTON SCIENTIFIC CORP (BSX), sold 32,900 shares at $44.03 ($1.4M) on 2021-06-24, disclosed to the SEC on 2021-06-28.
Open-market sale of $1.4M BSX by SVP, President, Urology Pelvic Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.03 | 16,450 | $724K | 50.0% |
| 2 | $44.03 | 16,450 | $724K | 50.0% |
| Total | $44.03 avg | 32,900 | $1.4M | 100% |